DFNA5

From Wikipedia, the free encyclopedia


Deafness, autosomal dominant 5
Identifiers
Symbol(s) DFNA5; ICERE-1
External IDs OMIM: 608798 MGI1889850 HomoloGene3242
RNA expression pattern

More reference expression data

Orthologs
Human Mouse
Entrez 1687 54722
Ensembl ENSG00000105928 ENSMUSG00000029821
Uniprot O60443 Q3TBE9
Refseq NM_004403 (mRNA)
NP_004394 (protein)
NM_018769 (mRNA)
NP_061239 (protein)
Location Chr 7: 24.7 - 24.76 Mb Chr 6: 50.14 - 50.19 Mb
Pubmed search [1] [2]

Deafness, autosomal dominant 5, also known as DFNA5, is a human gene.[1]

Hearing impairment is a heterogeneous condition with over 40 loci described. The protein encoded by this gene is expressed in fetal cochlea, however, its function is not known. Nonsyndromic hearing impairment is associated with a mutation in this gene.[1]

[edit] References

[edit] Further reading

  • van Camp G, Coucke P, Balemans W, et al. (1996). "Localization of a gene for non-syndromic hearing loss (DFNA5) to chromosome 7p15.". Hum. Mol. Genet. 4 (11): 2159-63. PMID 8589696. 
  • Andersson B, Wentland MA, Ricafrente JY, et al. (1996). "A "double adaptor" method for improved shotgun library construction.". Anal. Biochem. 236 (1): 107-13. doi:10.1006/abio.1996.0138. PMID 8619474. 
  • Yu W, Andersson B, Worley KC, et al. (1997). "Large-scale concatenation cDNA sequencing.". Genome Res. 7 (4): 353-8. PMID 9110174. 
  • Van Laer L, Van Camp G, van Zuijlen D, et al. (1998). "Refined mapping of a gene for autosomal dominant progressive sensorineural hearing loss (DFNA5) to a 2-cM region, and exclusion of a candidate gene that is expressed in the cochlea.". Eur. J. Hum. Genet. 5 (6): 397-405. PMID 9450185. 
  • Thompson DA, Weigel RJ (1998). "Characterization of a gene that is inversely correlated with estrogen receptor expression (ICERE-1) in breast carcinomas.". Eur. J. Biochem. 252 (1): 169-77. PMID 9523727. 
  • Van Laer L, Huizing EH, Verstreken M, et al. (1998). "Nonsyndromic hearing impairment is associated with a mutation in DFNA5.". Nat. Genet. 20 (2): 194-7. doi:10.1038/2503. PMID 9771715. 
  • Grottke C, Mantwill K, Dietel M, et al. (2000). "Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs.". Int. J. Cancer 88 (4): 535-46. PMID 11058868. 
  • Van Laer L, DeStefano AL, Myers RH, et al. (2003). "Is DFNA5 a susceptibility gene for age-related hearing impairment?". Eur. J. Hum. Genet. 10 (12): 883-6. doi:10.1038/sj.ejhg.5200878. PMID 12461698. 
  • Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899-903. doi:10.1073/pnas.242603899. PMID 12477932. 
  • Gregan J, Van Laer L, Lieto LD, et al. (2003). "A yeast model for the study of human DFNA5, a gene mutated in nonsyndromic hearing impairment.". Biochim. Biophys. Acta 1638 (2): 179-86. PMID 12853124. 
  • Hillier LW, Fulton RS, Fulton LA, et al. (2003). "The DNA sequence of human chromosome 7.". Nature 424 (6945): 157-64. doi:10.1038/nature01782. PMID 12853948. 
  • Yu C, Meng X, Zhang S, et al. (2004). "A 3-nucleotide deletion in the polypyrimidine tract of intron 7 of the DFNA5 gene causes nonsyndromic hearing impairment in a Chinese family.". Genomics 82 (5): 575-9. PMID 14559215. 
  • Bischoff AM, Luijendijk MW, Huygen PL, et al. (2004). "A novel mutation identified in the DFNA5 gene in a Dutch family: a clinical and genetic evaluation.". Audiol. Neurootol. 9 (1): 34-46. doi:10.1159/000074185. PMID 14676472. 
  • Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40-5. doi:10.1038/ng1285. PMID 14702039. 
  • Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121-7. doi:10.1101/gr.2596504. PMID 15489334. 
  • Masuda Y, Futamura M, Kamino H, et al. (2006). "The potential role of DFNA5, a hearing impairment gene, in p53-mediated cellular response to DNA damage.". J. Hum. Genet. 51 (8): 652-64. doi:10.1007/s10038-006-0004-6. PMID 16897187. 
  • Van Laer L, Meyer NC, Malekpour M, et al. (2007). "A novel DFNA5 mutation does not cause hearing loss in an Iranian family.". J. Hum. Genet. 52 (6): 549-52. doi:10.1007/s10038-007-0137-2. PMID 17427029.